IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

Go back to IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
(NASDAQ: ICCM) Delayed: 5.93 --0 (-0%)
Previous Close $5.93    52 Week High
Open $5.93    52 Week Low
Day High $5.93    P/E N/A 
Day Low $5.93    EPS
Volume 26,427